Bain Capital Life Sciences Investors, LLC (CIK 1703031) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-30). Recent activity: Sell HTFL (254,110 shares), Sell HTFL (797,133 shares), Sell HTFL (892,533 shares), Sell HTFL (56,224 shares), Buy KLRA (16.9M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-30 | Heartflow, Inc. (HTFL) | 10% Owner | Sell | 254,110 | $7.8M |
| 2026-04-30 | Heartflow, Inc. (HTFL) | 10% Owner | Sell | 797,133 | $23.4M |
| 2026-04-30 | Heartflow, Inc. (HTFL) | 10% Owner | Sell | 892,533 | $26.0M |
| 2026-04-30 | Heartflow, Inc. (HTFL) | 10% Owner | Sell | 56,224 | $1.7M |
| 2026-04-20 | Kailera Therapeutics, Inc. (KLRA) | 10% Owner | Buy | 16.9M | $0 |
| 2026-04-20 | Kailera Therapeutics, Inc. (KLRA) | 10% Owner | Buy | 4.1M | $0 |
| 2026-04-20 | Kailera Therapeutics, Inc. (KLRA) | 10% Owner | Buy | 1.6M | $25.0M |
| 2026-02-06 | Heartflow, Inc. (HTFL) | Insider | Sell | 2.0M | $56.1M |
| 2025-08-13 | Heartflow, Inc. (HTFL) | Insider | Buy | 12.0M | $0 |
| 2025-08-13 | Heartflow, Inc. (HTFL) | Insider | Buy | 433,924 | $6.6M |
Source: SEC Form 4 filings · as of 2026-04-30